Navigation Links
Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business
Date:5/18/2009

WAYNE, Pa., May 18 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (Nasdaq: ENCO), a full service multinational contract research organization (CRO) that provides design, development, and management capabilities for clinical trials and patient registries to many of the world's leading pharmaceutical companies, today announced that the initial non-binding letter of intent with respect to its U.S. business has been terminated and that the Company has entered into another letter of intent with Pierrel SpA, an international contract research organization listed on Milano's Stock Exchange.

Subject to the negotiation of a definitive agreement, pursuant to the letter of intent, Pierrel has the right to purchase the U.S. Line of Business for a purchase price equal to a percentage of the Company's U.S. backlog calculated as of the closing or $1.35 million, whichever is greater, less the amount, if any, that assumed current liabilities, less assumed current assets exceeds $350,000. In addition to the purchase price payable at closing, Pierrel will pay Encorium a 10% commission on the value of any new contract, net of pass-through costs, executed after the closing date but prior to December 31, 2009, which constitute part of the Company's pipeline at closing.

Encorium Group plans to file a Current Report on Form 8-K with the United States Securities and Exchange Commission today containing a more detailed description of the parties' rights and obligations under the agreement.

About Encorium Group, Inc.

Encorium Group, Inc. is a global clinical research organization specializing in the design and management of complex clinical trials and Patient Registries for the pharmaceutical, biotechnology and medical device industries. The Company's mission is to provide its clients with high q
'/>"/>

SOURCE Encorium Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Encorium Group Signs $6.2 Million of New Contracts Mainly for Vaccines Clinical Trials
2. Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig
3. Baxter and The Alzheimers Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimers Disease
4. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
5. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
6. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
7. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
8. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
9. Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
10. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
11. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... N.C. , Feb. 27, 2015 Pharmaceutical ... of managing multiple products for the same indication. This ... those that want to prevent one of their brands ... According to recent research by benchmarking firm, ... products as independent brands rather than together as part ...
(Date:2/27/2015)... , Feb. 27, 2015  Acsis Inc., the market ... solutions, announced today that John DiPalo , Acsis, ... Supply & Demand Chain Executive 2015 Provider Pro ... are leading initiatives to help prepare their companies, and ... business climate. This year,s list of Provider Pros to ...
(Date:2/27/2015)... HOUSTON, TX , Feb. 27, 2015 /PRNewswire/ - ESSA ... Bloom Burton & Co. Ltd. ("Bloom Burton") today announced ... "Lock-Up") 2,353,130 common shares of the Company ("Common Shares") ... the Lock-Up. Of the Common Shares released from the ... release from the Lock-Up while the remainder will be ...
Breaking Medicine Technology:New Report Details How to Expand a Pharmaceutical Product Portfolio without Cannibalizing an Established Brand 2Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4
... Sheets: MDBX ) ( www.medboxinc.com ) announced ... and will operate the company as a wholly-owned subsidiary. ... in 2008 and has generated revenues of over $6 ... patented biometric medicine dispensing system that can dispense a ...
... Medical Product Outsourcing magazine (MPO) hosts its ... MPO Symposium), March 19-21 at the Costa Rica Marriott ... conference, consisting of networking, interactive education, strategic planning and ... will open in early January. www.medicaldevicecr.com ...
Cached Medicine Technology:Medical Device Costa Rica: An MPO Symposium Helps Firms Connect, Learn & Master Global Manufacturing Skills 2
(Date:2/27/2015)... Altec Products, Inc., announced today that ADSS ... Management Partner of the Year. ADSS Global provides Sage ... complimentary solutions for their customers across the world. Altec ... to provide clients with paperless solutions that integrate seamlessly ... thrilled to recognize ADSS Global for their expertise in ...
(Date:2/27/2015)... 2015 The V Foundation for Cancer ... organizations, is excited to announce numerous promotions taking place ... many long-standing partnerships highlight The V Foundation’s significant work ... ways for all to get involved. Awarding 100 ... research, The V Foundation has funded more than $130 ...
(Date:2/27/2015)... 27, 2015 On February 24 2015, Harper’s ... Botox ,” that details the development of RT001, a ... its way through FDA trials. For those afraid of needles, ... very attractive. Of course, if the drug ultimately gets FDA ... physician’s office. (see: goo.gl/PQvQwk) , “As the article notes, the ...
(Date:2/27/2015)... The Dawn Greene Hospice, a 10-bed facility located on the ... Upper East Side, was officially dedicated and blessed at a ... Michael Cardinal Dolan. , Thomas J. Fahey, Jr., MD, chairman ... of the ArchCare Board of Trustees, presided over the event ... of MMW, and Christina McInerney, president and CEO of The ...
(Date:2/27/2015)... The UC Davis Huntington’s Disease Center, ... it a beacon of hope for people with Huntington’s ... by the national society committed to the values that ... of America — as a Level 1 Huntington’s Disease ... center’s service to over 300 families coping with Huntington's ...
Breaking Medicine News(10 mins):Health News:Altec Announces 2014 Sage ERP Document Management Partner of the Year Award Recipient 2Health News:The V Foundation Reinforces its Fight Against Cancer with New and Extended Partnerships 2Health News:The V Foundation Reinforces its Fight Against Cancer with New and Extended Partnerships 3Health News:Is Topical Botox the Next Big Thing? 2Health News:The Dawn Greene Hospice Is Officially Dedicated 2Health News:The Dawn Greene Hospice Is Officially Dedicated 3Health News:UC Davis Huntington's Disease Center Receives Level 1 Designation 2Health News:UC Davis Huntington's Disease Center Receives Level 1 Designation 3
... reported diagnosis is a reminder of the damage drugs ... MONDAY, June 23 (HealthDay News) -- The shocking revelation ... may have a mild form of emphysema leaves experts ... Winehouse, in addition to her well-publicized use of drugs ...
... beyond nurse-to-nurse training and create more ... encompassing, ... Technologies(R), a leading,provider of radio frequency identification monitoring systems ... support program associated with its Safe Place(R),Infant Security Solution ...
... Blacks and Hispanics appear less likely to undergo colorectal ... access and language barriers, according to a report in ... Medicine , one of the JAMA/Archives journals. However, other ... , Colorectal cancer screening rates lag behind those for ...
... China Medicine,Corporation (OTC Bulletin Board: CHME; "China ... developer of ethical and over-the-counter drugs,traditional Chinese ... and medical formulations in the People,s Republic ... obtained the exclusive rights to,sell 2,300 products ...
... The pharmaceutical,company Pfizer Inc. has agreed to ... of the Clean Air Act at its former ... Environmental Protection,Agency (EPA) announced today. Today,s settlement is ... regulations that are designed to control the,emissions of ...
... study found poor reflexes, unstable posture, weakened hands ... News) -- In otherwise healthy older people, subtle ... of stroke and death, Italian researchers report. , ... posture, resting tremors and differences in hand strength, ...
Cached Medicine News:Health News:Young Pop Star's Emphysema Startles Experts 2Health News:Young Pop Star's Emphysema Startles Experts 3Health News:RF Technologies(R) Introduces Enhanced Clinical Support Service, Step-by-Step, a Comprehensive Program Designed to Ensure Infant Security 2Health News:Study evaluates factors associated with racial disparities in colon cancer screening 2Health News:China Medicine Maintains Exclusive Rights to Distribute 2,300 Pharmaceutical Products 2Health News:China Medicine Maintains Exclusive Rights to Distribute 2,300 Pharmaceutical Products 3Health News:Pfizer to Pay $975,000 for Alleged Clean Air Violations at Connecticut Facility 2Health News:Subtle Nervous System Problems Signal Stroke Risk 2
Advanced operating microscope with high-resolution apochromatic optics. Senso-servo drive to keep the microscope in perfect balance even if parts are moved or mounted elsewhere....
Advanced operating microscope with zoom and variable focus up to 500 mm....
... microscope provides surgeons with brighter, crisper, magnified ... ideal for many minimally invasive spine procedures. ... every point of contact. The first graphical ... microscope allows intuitive user guidance similar to ...
The Horizontal-Vertical (H/V) lumbar valve system is the only differential pressure valve for lumbo-peritoneal shunting, which addresses orthostatic overdrainage....
Medicine Products: